Table 3.
Group-wise distribution of clinically involved oral sites in Groups I–IV
Sites | Group I | Group II | Group III | Group IV |
---|---|---|---|---|
1–2 | 1 | 0 | 0 | 0 |
3–4 | 4 | 0 | 2 | 0 |
5–6 | 1 | 3 | 1 | 0 |
7–8 | 2 | 6 | 6 | 4 |
9–10 | 2 | 1 | 1 | 3 |
>10 | 0 | 0 | 0 | 3 |
Group-wise distribution of clinically involved oral sites in Groups I–IV
Sites | Group I | Group II | Group III | Group IV |
---|---|---|---|---|
1–2 | 1 | 0 | 0 | 0 |
3–4 | 4 | 0 | 2 | 0 |
5–6 | 1 | 3 | 1 | 0 |
7–8 | 2 | 6 | 6 | 4 |
9–10 | 2 | 1 | 1 | 3 |
>10 | 0 | 0 | 0 | 3 |